Paul A. Wagner
2023 - Forte Biosciences
In 2023, Paul A. Wagner earned a total compensation of $1.5M as Chairman, President and Chief Executive Officer at Forte Biosciences, a 18% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $340,725 |
|---|---|
| Salary | $619,500 |
| Stock Awards | $489,950 |
| Total | $1,450,175 |
Wagner received $619.5K in salary, accounting for 43% of the total pay in 2023.
Wagner also received $340.7K in non-equity incentive plan and $490K in stock awards.
Rankings
In 2023, Paul A. Wagner's compensation ranked 820th out of 3,006 executives tracked by ExecPay. In other words, Wagner earned more than 72.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 820 out of 3,006 | 73rd |
Division Manufacturing | 479 out of 1,650 | 71st |
Major group Chemicals And Allied Products | 327 out of 918 | 64th |
Industry group Drugs | 319 out of 881 | 64th |
Industry Pharmaceutical Preparations | 212 out of 637 | 67th |
Source: SEC filing on December 31, 2024.
Wagner's colleagues
We found one more compensation record of an executive who worked with Paul A. Wagner at Forte Biosciences in 2023.
2023
Antony Riley
Forte Biosciences